Meeting
2021 Genitourinary Cancers Symposium
p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.
Authors
Takuma Kato
Kagawa University Graduate School of Medicine, Kagawa, Japan
Takuma Kato , Mikio Sugimoto , Yoshiyuki Kakehi , Nobuo Shinohara , Shin Egawa , Hiroshi Sasaki , Toshihiro Saito , Toshiki Tanikawa , Masafumi Matsumura , Katsuyoshi Hashine , Shusuke Akamatsu , Osamu Ogawa , Isao Hara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
UMIN 000009876
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 153)
DOI
10.1200/JCO.2021.39.6_suppl.153
Abstract #
153
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Persistent need for systematic biopsy for those on active surveillance for early-stage prostate cancer.
First Author: Mary Fakunle
Poster
2021 Genitourinary Cancers Symposium
The impact of a positive family history on clinical and pathologic outcomes of active surveillance for prostate cancer.
First Author: Adam Schneider
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2016 ASCO Annual Meeting
Plasma caveolin-1 to predict disease reclassification in men with early stage prostate cancer in active surveillance.
First Author: Spyridon P Basourakos